Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biokinetics Study for F-18 FDG for Dose Reduction in Pediatric Molecular Imaging

NCT03107325 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03107325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03107325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biokinetics Study for F-18 FDG for Dose Reduction in Pediatric Molecular Imaging
Lead sponsor
Boston Children's Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
February 1, 2019
Completion date
October 1, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood neoplasm